AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 142 filers reported holding AMICUS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,621,000 | -32.8% | 527,430 | +0.0% | 0.00% | -40.0% |
Q3 2016 | $3,903,000 | +51.5% | 527,392 | +11.7% | 0.01% | +66.7% |
Q2 2016 | $2,577,000 | -23.0% | 472,055 | +19.1% | 0.00% | -25.0% |
Q1 2016 | $3,348,000 | -11.5% | 396,235 | +1.6% | 0.00% | -20.0% |
Q4 2015 | $3,785,000 | -30.3% | 390,174 | +0.5% | 0.01% | -28.6% |
Q3 2015 | $5,432,000 | +17.3% | 388,287 | +18.6% | 0.01% | +16.7% |
Q2 2015 | $4,632,000 | +3963.2% | 327,335 | +3030.6% | 0.01% | – |
Q1 2015 | $114,000 | +32.6% | 10,456 | +1.3% | 0.00% | – |
Q4 2014 | $86,000 | +68.6% | 10,320 | +19.5% | 0.00% | – |
Q3 2014 | $51,000 | +121.7% | 8,636 | +25.8% | 0.00% | – |
Q2 2014 | $23,000 | -87.3% | 6,864 | -92.2% | 0.00% | – |
Q1 2014 | $181,000 | -13.4% | 87,527 | -1.4% | 0.00% | – |
Q4 2013 | $209,000 | +2.0% | 88,750 | +0.5% | 0.00% | – |
Q3 2013 | $205,000 | +3.5% | 88,313 | +3.7% | 0.00% | – |
Q2 2013 | $198,000 | – | 85,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |